This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Bicuspid/Mitral Remove CMS Remove TAVR
article thumbnail

Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure

CardiacWire

JULY 28, 2024

These two acquisitions could impact Edwards’ structural heart and heart failure portfolios in unique and meaningful ways… JenaValve’s Trilogy TAVR system doesn’t yet have FDA approval, but is CE Marked for both aortic regurgitation and aortic stenosis, which is notable given that all other TAVR systems only address aortic stenosis.

Heart Failure 59
Heart Failure Aortic TAVR Critical Care 59
article thumbnail

New Legislation Speeds Progress on Patient Access to New Technologies

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

The TVT Registry has been approved by the Centers for Medicare and Medicaid Services to meet registry requirements outlined in the national coverage decisions for transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR). Download the PDF version Advocacy Quality Improvement Technology

Technology 40
Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join thousands of Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024